Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

NMTC

NeuroOne Medical Technologies Corp

Jan 21 • 04:00PM ET

1.02

Dollar change -0.03
Percentage change -2.86	%

Healthcare • Medical Devices • USA • NASD

Peers: STXS NVCR PEN CNMD INGN CERS SENS AXGN TTOO

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.46	Insider Own	13.61%	Shs Outstand	30.82M	Perf Week	-8.93%
Market Cap	31.48M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	26.66M	Perf Month	28.98%
Income	-12.32M	PEG	-	EPS next Q	-	Inst Own	19.40%	Short Float	0.26%	Perf Quarter	9.68%
Sales	3.45M	P/S	9.12	EPS this Y	-	Inst Trans	-1.49%	Short Ratio	0.34	Perf Half Y	18.88%
Book/sh	0.03	P/B	38.25	EPS next Y	-	ROA	-182.93%	Short Interest	0.07M	Perf Year	-24.44%
Cash/sh	0.05	P/C	21.56	EPS next 5Y	-	ROE	-348.39%	52W Range	0.55 - 1.59	Perf YTD	23.50%
Dividend Est.	-	P/FCF	-	EPS past 5Y	23.14%	ROI	-1211.93%	52W High	-35.85%	Beta	0.67
Dividend TTM	-	Quick Ratio	0.84	Sales past 5Y	149.45%	Gross Margin	31.27%	52W Low	85.12%	ATR (14)	0.12
Dividend Ex-Date	-	Current Ratio	2.03	EPS Y/Y TTM	29.02%	Oper. Margin	-344.26%	RSI (14)	58.35	Volatility	14.75% 12.17%
Employees	17	Debt/Eq	0.32	Sales Y/Y TTM	1.33%	Profit Margin	-356.74%	Recom	3.00	Target Price	2.00
Option/Short	Yes / Yes	LT Debt/Eq	0.23	EPS Q/Q	15.98%	Payout	-	Rel Volume	2.37	Prev Close	1.05
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-63.29%	Earnings	Dec 17 BMO	Avg Volume	206.04K	Price	1.02
SMA20	7.96%	SMA50	24.17%	SMA200	12.46%	Trades		Volume	466,054	Change	-2.86%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-29-22	Downgrade	Craig Hallum	Buy → Hold	$6 → $2

Jan-11-25 09:30AM	NeuroOne Reports Record Revenue Boost in Q1 2025 (TipRanks)
Jan-10-25 08:30AM	NeuroOne Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million (GlobeNewswire)
Jan-06-25 08:30AM	NeuroOne Announces Change of Virtual Investor Webinar to Friday, January 10, 2024 (GlobeNewswire) +13.04%
Jan-03-25 08:30AM	NeuroOne Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST (GlobeNewswire) +11.54%
Dec-17-24 08:30AM	NeuroOne Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025 (GlobeNewswire)
08:30AM	Loading…
Dec-04-24 08:30AM	NeuroOne to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time (GlobeNewswire)
Dec-03-24 03:45PM	Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing (ACCESS Newswire)
Nov-13-24 09:30AM	NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event (ACCESSWIRE)
Oct-31-24 04:01PM	NeuroOne Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF Ablation System (GlobeNewswire)
Oct-24-24 09:00AM	NeuroOne Medical Technologies to Present at the 2024 ThinkEquity Conference (GlobeNewswire) +5.26%
Sep-24-24 09:30AM	NeuroOne Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference (GlobeNewswire) +5.40%
Sep-10-24 09:00AM	NeuroOne Announces Breakthrough Case Completed with OneRF Ablation System at the University Hospitals in Cleveland (GlobeNewswire) +11.13%
Sep-05-24 06:23PM	NeuroOne to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Aug-14-24 04:00PM	NeuroOne Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-12-24 11:30AM	NeuroOne to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14 (GlobeNewswire)
09:00AM	Loading…
Aug-05-24 09:00AM	NeuroOne Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility (GlobeNewswire) +7.25%
Jun-25-24 09:00AM	NeuroOne Announces First in Human Ablations Completed with OneRF Ablation System (GlobeNewswire) -19.08%
Jun-20-24 09:30AM	NeuroOne Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation (GlobeNewswire)
May-14-24 08:57PM	NMTC Stock Earnings: NeuroOne Medical Tech Misses EPS, Misses Revenue for Q2 2024 (InvestorPlace) -7.02%
04:00PM	NeuroOne Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
May-10-24 02:43PM	NeuroOne to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14 (GlobeNewswire)
Apr-10-24 09:00AM	NeuroOne CEO Dave Rosa Featured on Bloomberg Technology (GlobeNewswire)
Apr-09-24 09:05AM	NeuroOne Announces First Implant of OneRF Ablation Electrodes (GlobeNewswire)
Apr-04-24 09:00AM	NeuroOne CEO Dave Rosa Featured on Fox Business Network's Varney & Co. (GlobeNewswire)
Mar-26-24 09:00AM	NeuroOne Initiates Limited Commercial Launch of OneRF Ablation System (GlobeNewswire) -8.66%
Mar-08-24 12:00PM	NeuroOne to Participate in the 36th Annual Roth Conference (GlobeNewswire)
Feb-23-24 05:10PM	NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +8.41%
Feb-13-24 04:00PM	NeuroOne Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire) -23.40%
Feb-08-24 03:30PM	NeuroOne to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13 (GlobeNewswire)
Dec-14-23 04:15PM	NeuroOne Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire) +12.42% -11.05%
08:00AM	Loading…
Dec-11-23 08:00AM	NeuroOne Receives FDA 510(k) Clearance to Market its OneRF Ablation System (GlobeNewswire) -10.94%
Dec-07-23 04:30PM	NeuroOne to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14 (GlobeNewswire) +7.19% +7.26%
Nov-16-23 08:00AM	NeuroOne Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe (GlobeNewswire) -8.33%
Nov-14-23 05:15PM	NeuroOne Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +11.02%
Nov-07-23 08:00AM	NeuroOne Provides Progress Update on FDA 510(k) Submission for OneRF Ablation System (GlobeNewswire) +7.48%
Oct-13-23 09:30AM	NeuroOne to Present at the ThinkEquity Conference on October 19, 2023 (GlobeNewswire)
Sep-15-23 01:01AM	Insider Buying: CFO Ronald Mcclurg Acquires 50,900 Shares of NeuroOne Medical Technologies Corp ... (GuruFocus.com) +6.00%
Sep-06-23 04:00PM	NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-14-23 04:00PM	NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-08-23 04:00PM	NeuroOne® to Report Third Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on August 14 (GlobeNewswire)
Jul-25-23 08:00AM	NeuroOne Medical Technologies Corporation Announces Pricing of Public Offering of Common Stock (GlobeNewswire) -33.33%
Jul-24-23 04:03PM	NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock (GlobeNewswire) -9.14%
Jun-12-23 08:35AM	NeuroOne® Submits 510(k) Application to FDA for OneRF Ablation System (GlobeNewswire) +6.50%
May-17-23 09:00AM	NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode in Robotic Neurosurgery (GlobeNewswire)
May-11-23 04:00PM	NeuroOne® Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
12:17PM	NeuroOne® to Report Second Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on May 11 (GlobeNewswire)
May-10-23 09:00AM	NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode Performed at Mayo Clinic (GlobeNewswire)
May-09-23 07:15AM	Sidoti's Micro-Cap Virtual May Conference (ACCESSWIRE)
May-05-23 03:08PM	NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
09:00AM	NeuroOne® to Present at the Sidoti Micro-Cap Virtual Conference on May 10 (GlobeNewswire)
May-02-23 09:00AM	NeuroOne® Announces U.S. Commercial Launch of Evo® sEEG Electrodes (GlobeNewswire) -10.37%
Apr-27-23 04:00PM	NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-06-23 09:15AM	Minimally Invasive Surgery - This Company's Successful Trial Could Help Eliminate The Need For An Incision In Patients With Back Pain (ACCESSWIRE)
Mar-16-23 07:30AM	NeuroOne® Successfully Completes Initial Animal Implant of Novel Thin Film Paddle Lead for Spinal Cord Stimulation (PR Newswire) -5.26%
Mar-09-23 09:00AM	NeuroOne®#¹;to Participate in the 35th Annual Roth Conference (PR Newswire)
Mar-07-23 07:30AM	NeuroOne® Awarded U.S. Patent Covering Novel and Proprietary Thin Film Electrode Platform (PR Newswire) +11.84%
Feb-14-23 04:00PM	NeuroOne® Reports First Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update (PR Newswire) -16.02%
Feb-09-23 09:00AM	NeuroOne® to Report First Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on February 14 (PR Newswire) +13.01%
Jan-30-23 09:00AM	NeuroOne® Issues Letter to Shareholders (PR Newswire)
Dec-22-22 09:00AM	NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2022 Financial Results (PR Newswire) -25.40%
Dec-13-22 04:00PM	NeuroOne® to Host Fiscal Fourth Quarter Corporate Update (PR Newswire) +5.74% +17.65%
Dec-08-22 09:00AM	NeuroOne® to Report Fourth Quarter and Fiscal Year 2022 Financial Results and Provide Corporate Update on December 13 (PR Newswire) +9.91%
Dec-06-22 09:00AM	NeuroOne® Successfully Completes Feasibility Study with its OneRF Ablation System (PR Newswire) +14.72%
Nov-30-22 09:00AM	NeuroOne® Ships Initial Zimmer Biomet Order for its Evo® sEEG System for Less than 30 Day Use (PR Newswire) +6.02%
Nov-22-22 09:00AM	NeuroOne® to Ring Nasdaq Stock Market Closing Bell on November 22 (PR Newswire) +8.33%
Nov-21-22 11:00AM	NeuroOne® CEO Dave Rosa Featured on Fox Business Network's 'Mornings with Maria' (PR Newswire) +42.86%
Oct-25-22 09:00AM	NeuroOne® Receives FDA 510(k) Clearance to Market its Evo® sEEG System for Less than 30 Day Use (PR Newswire) -10.06%
Sep-22-22 09:00AM	NeuroOne Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Aug-11-22 04:00PM	NeuroOne® Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update (PR Newswire)
Aug-09-22 09:00AM	NeuroOne® Submits Special 510(k) to FDA for Evo® sEEG Electrode (PR Newswire)
Aug-04-22 09:00AM	NeuroOne® to Report Third Quarter Fiscal Year 2022 Financial Results on August 11 (PR Newswire) -6.29%
Aug-03-22 09:00AM	NeuroOne® Announces $3.5 Million Accelerated Milestone Payment from Zimmer Biomet for Evo® sEEG Electrode (PR Newswire) +45.83%
Jul-12-22 09:00AM	NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode (PR Newswire)
Jun-02-22 08:47AM	NeuroOne® Issues Letter to Stockholders in Connection With 2022 Annual Meeting of Stockholders (PR Newswire) -6.16%
May-19-22 09:30AM	NeuroOne® to Present Its Breakthrough Technology for Monitoring Neural Activity at the H.C. Wainwright Global Investment Conference on May 25 (PR Newswire) +29.57%
May-16-22 04:30PM	NeuroOne Provides Evo® sEEG Update (PR Newswire) +9.81%
May-12-22 04:05PM	NeuroOne Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update (PR Newswire)
May-03-22 09:00AM	NeuroOne® to Report Second Quarter Fiscal Year 2022 Financial Results on May 12 (PR Newswire)
Apr-18-22 10:00AM	NeuroOne® to Present its Disruptive Next-Generation Diagnostic Electrode Technology at the NobleCon18 Investor Conference on April 20, 2022 (PR Newswire)
Mar-30-22 10:00AM	NeuroOne® Investor Call Replay Available Through April 11th (PR Newswire)
Mar-28-22 07:05PM	NeuroOne® to Host Investor Call About Recent Disclosures Tomorrow March 29th at 10:00 am ET (PR Newswire) -46.85%
Mar-15-22 07:41AM	What You Need To Know About NeuroOne Medical Technologies Corporation's (NASDAQ:NMTC) Investor Composition (Simply Wall St.)
Mar-04-22 09:00AM	NeuroOne Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Mar-03-22 09:00AM	NeuroOne to Present its Game-Changing Neuroscientific Technology at the Oppenheimer 32nd Annual Healthcare Conference and 34th Annual ROTH Conference (PR Newswire)
Mar-02-22 09:00AM	NeuroOne® Releases Successful Completion of Long-Term Stimulation Tests for its Novel Thin Film Platform Electrode Technology (PR Newswire)
Feb-14-22 04:01PM	NeuroOne Reports First Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update (PR Newswire) -13.75%
Feb-08-22 09:00AM	NeuroOne® Medical Technologies Corporation Releases Successful Long-Term Recording Test Data for its Novel Thin Film Platform Electrode Technology (PR Newswire) +6.07%
Feb-02-22 04:01PM	NeuroOne to Host First Quarter Fiscal Year 2022 Earnings Call (PR Newswire)
Jan-28-22 10:07AM	36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022 (ACCESSWIRE) +8.33%
Jan-18-22 08:00AM	NeuroOne Appoints Chad Wilhelmy, as Vice President of Quality Control and Regulatory Affairs (PR Newswire)
Dec-20-21 11:00AM	NeuroOne Featured on The Medical Alley Podcast: "A Conversation with Dave Rosa, President and CEO, NeuroOne" (PR Newswire)
Dec-16-21 06:38PM	AWM Investment Company, Inc. Buys Destination XL Group Inc, LiqTech International Inc, Gambling. ... (GuruFocus.com) -10.26%
Dec-15-21 08:00AM	NeuroOne Reports Fourth Fiscal Quarter and Full Fiscal Year 2021 Financial Results and Provides Corporate Update (PR Newswire)
Dec-06-21 01:55PM	NeuroOne to Host Fourth Quarter 2021 Earnings Call (PR Newswire) +10.24%
Oct-13-21 08:02AM	NeuroOne Medical Technologies Corporation Announces Pricing of Public Offering of Common Stock (PR Newswire) -29.37%
Oct-12-21 07:03PM	NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock (PR Newswire)
Sep-23-21 09:00AM	NeuroOne® Medical Technologies Corporation Announces Successful Completion of Feasibility Study for Ablation Electrode (PR Newswire)
Sep-09-21 09:00AM	NeuroOne to Present at H.C. Wainwright 23rd Annual Global Investment Conference (PR Newswire) -13.07%
Sep-07-21 02:21PM	NeuroOne® Medical Technologies Corporation Receives FDA 510(k) Clearance for its Evo® sEEG Electrode (PR Newswire) +14.62%
Aug-25-21 11:00AM	NeuroOne Featured on Cheddar News (VIDEO): "Can This Brain Implant Save Lives?" (PR Newswire) -8.89%

NeuroOne Medical Technologies Corp. is a medical technology company, which engages in the development and commercialization of thin film electrode technology for continuous electroencephalogram and stereoelectrocencephalography recording, spinal cord stimulation, brain stimulation, and ablation solutions. The company was founded by Mark Christianson on August 20, 2009 and is headquartered in Eden Prairie, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Christianson Mark	Business Development Director	Jun 06 '24	Sale	0.88	2,189	1,918	295,035	Jun 11 03:34 PM
Christianson Mark	Business Development Director	Jun 05 '24	Sale	0.88	25,800	22,663	297,224	Jun 07 09:49 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NMTC

NeuroOne Medical Technologies Corp

Upgrade your FINVIZ experience